Jan 24 (Reuters) - ELEGEN:
* ELEGEN AND GSK SIGN COLLABORATION AND LICENSING AGREEMENT TO FURTHER DEVELOP ELEGEN’S CELL-FREE DNA PRODUCTION TECHNOLOGY
* ELEGEN - TERMS OF AGREEMENT INCLUDE UPFRONT FEES AND PURCHASE COMMITMENTS OF ELEGEN'S ENFINIA DNA
* ELEGEN - AGREEMENT PROVIDES ELEGEN UP TO $35 MILLION IN NEAR-TERM FINANCIAL AND DEVELOPMENT SUPPORT Further company coverage: